Dr.reddy's Laboratories Ltd — Rituximab Exporter Profile
Indian Pharmaceutical Exporter · #1 for Rituximab · $3.2M export value · DGFT Verified
Dr.reddy's Laboratories Ltd is the #1 Indian exporter of Rituximab with $3.2M in export value and 64 verified shipments. Dr.reddy's Laboratories Ltd holds a 16.7% market share in Rituximab exports across 17 countries.
Dr.reddy's Laboratories Ltd — Rituximab Export Profile: Buyers & Destinations
Where Does Dr.reddy's Laboratories Ltd Export Rituximab?
| Country | Value | Shipments | Share |
|---|---|---|---|
| RUSSIA | $351.5K | 9 | 30.6% |
| PHILIPPINES | $236.7K | 8 | 20.6% |
| MAURITIUS | $131.5K | 5 | 11.5% |
| UNITED STATES | $102.8K | 12 | 9.0% |
| BANGLADESH | $100.0K | 2 | 8.7% |
| KENYA | $98.8K | 2 | 8.6% |
| GERMANY | $89.9K | 2 | 7.8% |
| MALDIVES | $12.7K | 1 | 1.1% |
| CANADA | $11.5K | 2 | 1.0% |
| ALGERIA | $6.3K | 3 | 0.5% |
Dr.reddy's Laboratories Ltd exports Rituximab to 17 countries. The largest destination is RUSSIA accounting for 30.6% of Dr.reddy's Laboratories Ltd's Rituximab shipments, followed by PHILIPPINES (20.6%) and MAURITIUS (11.5%). These destinations reflect Dr.reddy's Laboratories Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rituximab from Dr.reddy's Laboratories Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| JSC R-PHARM | RUSSIA | $351.5K | 9 |
| DR.REDDYS LABORATORIES PHILIPPINES | PHILIPPINES | $236.7K | 8 |
| HYPERPHARM LTD | MAURITIUS | $131.5K | 5 |
| HEALTHCARE PHARMACEUTICALS LTD., | BANGLADESH | $100.0K | 2 |
| SYNTEGON TECHNOLOGY GMBH | GERMANY | $89.9K | 2 |
| UPS WAREHOUSE | UNITED STATES | $63.6K | 2 |
| NELSON LABORATORIES, LLC | UNITED STATES | $37.7K | 3 |
| STATE TRADING ORGANIZATION PLC, | MALDIVES | $12.7K | 1 |
| HEALTH CANADA, OTTAWA | CANADA | $11.5K | 2 |
| HOPITAL CENTRAL DE L ARMEE | ALGERIA | $3.9K | 1 |
Dr.reddy's Laboratories Ltd supplies Rituximab to 24 buyers globally. The largest buyer is JSC R-PHARM (RUSSIA), followed by DR.REDDYS LABORATORIES PHILIPPINES (PHILIPPINES) and HYPERPHARM LTD (MAURITIUS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rituximab Export Value and How Much Does Dr.reddy's Laboratories Ltd Contribute?
India exported $9.4M worth of Rituximab through 1,215 shipments from 164 suppliers to 104 countries, serving 292 buyers globally. Dr.reddy's Laboratories Ltd contributes $3.2M to this total, accounting for 16.7% of India's Rituximab exports. Dr.reddy's Laboratories Ltd ships Rituximab to 17 countries through 24 buyers.
What Is the Average Shipment Value for Dr.reddy's Laboratories Ltd's Rituximab Exports?
Dr.reddy's Laboratories Ltd's average Rituximab shipment value is $50.0K per consignment, based on 64 shipments totaling $3.2M. The largest destination is RUSSIA (30.6% of Dr.reddy's Laboratories Ltd's Rituximab exports).
How Does Dr.reddy's Laboratories Ltd Compare to Other Indian Rituximab Exporters?
Dr.reddy's Laboratories Ltd ranks #1 among 164 Indian Rituximab exporters with a 16.7% market share. The top 3 exporters are RELIANCE LIFE SCIENCES PRIVATE LIMITED ($4.1M), DR.REDDY'S LABORATORIES LTD ($3.2M), DR REDDYS LABORATORIES LIMITED ($550.0K). Dr.reddy's Laboratories Ltd processed 64 shipments to 17 destination countries.
What Rituximab Formulations Does Dr.reddy's Laboratories Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RITUXIMAB WORKING CELL BANK | $100.0K | 2 |
| RITUXIMAB(R-DNA ORIGIN)BULK(QTY:275 GMS) | $100.0K | 2 |
| RITUXIMAB 500MG/50ML(QTY:290 VIALS) | $50.0K | 1 |
| RITUXIMAB PLACEBO 10ML(FOR TESTING PURPO | $50.0K | 1 |
| REDDITUX 10MG/MLCONCENTRATE FOR SOLUTIONFOR INFUSION(IV)(RITUXIMAB)(50 ML PER VIAL)(QTY:1900 VIALS) | $50.0K | 1 |
| RITUXIMAB WCB(WORKING CELL BANK)(QTY:3 VIALS) | $50.0K | 1 |
| RITUXIMAB WCB(WORKING CELL BANK)(QTY:5 VIALS) | $50.0K | 1 |
| RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 20.5 MG/ML WITH BUFFER SOLUTION 116,466 L(QTY: 2387.553 GMS) | $50.0K | 1 |
| RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 19.6 MG/ML WITH BUFFER SOLUTION 123,350 L(QTY: 2417.66 GMS) | $50.0K | 1 |
| RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 19 MG/ML WITH BUFFER SOLUTION123,355 L(QTY: 2343.745 GMS) | $50.0K | 1 |
Dr.reddy's Laboratories Ltd exports 61 distinct Rituximab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RITUXIMAB WORKING CELL BANK with 2 shipments worth $100.0K.
How Does Dr.reddy's Laboratories Ltd Compare to Nearest Rituximab Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $4.1M | 102 | 18 | $40.1K |
| 1 | DR.REDDY'S LABORATORIES LTD ★ | $3.2M | 64 | 17 | $50.0K |
| 3 | DR REDDYS LABORATORIES LIMITED | $550.0K | 11 | 5 | $50.0K |
| 5 | HETERO BIOPHARMA LIMITED | $400.0K | 8 | 4 | $50.0K |
Dr.reddy's Laboratories Ltd ranks #1 among 164 Indian Rituximab exporters. Average shipment value of $50.0K compared to the market average of $57.4K. The closest competitors by value are RELIANCE LIFE SCIENCES PRIVATE LIMITED and DR REDDYS LABORATORIES LIMITED.
Which Indian Ports Ship Rituximab Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 389 | 32.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 325 | 26.7% |
| Bombay Air | 85 | 7.0% |
| Bombay Air Cargo | 58 | 4.8% |
| HYDERABAD ACC (INHYD4) | 46 | 3.8% |
| DELHI AIR CARGO ACC (INDEL4) | 45 | 3.7% |
| DELHI AIR | 35 | 2.9% |
| AHEMDABAD AIR | 26 | 2.1% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rituximab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rituximab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Dr.reddy's Laboratories Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 65 individual customs records matching Dr.reddy's Laboratories Ltd exporting Rituximab, covering 61 formulations to 17 countries via 24 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 292+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rituximab Export Data from Dr.reddy's Laboratories Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dr.reddy's Laboratories Ltd's Rituximab exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Dr.reddy's Laboratories Ltd
Company Profile
0 products · $0 total trade · 0 categories
Rituximab Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Dr.reddy's Laboratories Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rituximab. For current shipment-level data, contact TransData Nexus.